Clinical trial
Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or…
NCT00005974 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00005974 |
|---|---|
| Title | Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma |
| Official title | A Phase II Study of Flavopiridol (HMR 1275; NSC 649890) in Patients With Previously Untreated Metastatic or Locally Advanced Soft Tissue Sarcoma |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug |
| Interventions | alvocidib |
| Enrollment | 18 |
| Start date | Jul 4, 2000 |
| Primary completion | Nov 7, 2002 |
| Completion | Sep 22, 2008 |
| First posted | May 3, 2004 |
| Last update posted | Apr 8, 2020 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: